Bayesian Capital Management, LP Lannett CO Inc Transaction History

Bayesian Capital Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$6.36 - $10.05 $117,437 - $185,573	-18,465 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$8.49 - $12.81 $22,923 - $34,587	-2,700 Reduced 12.76%	18,465 $163,000
Q3 2019 Nov 13, 2019	BUY	$5.58 - $14.47 $118,100 - $306,257	21,165 New	21,165 $237,000
Q2 2019 Aug 13, 2019	SELL	$5.22 - $9.08 $122,148 - $212,472	-23,400 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$5.35 - $9.82 $125,189 - $229,788	23,400 New	23,400 $184,000
Q1 2018 May 15, 2018	SELL	$14.7 - $24.95 $232,260 - $394,210	-15,800 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$19.9 - $29.25 $314,420 - $462,150	15,800	15,800 $367,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.